Sarepta stock surges more than 10% as results top expectations, drug given priority review

Australia News News

Sarepta stock surges more than 10% as results top expectations, drug given priority review
Australia Latest News,Australia Headlines
  • 📰 MarketWatch
  • ⏱ Reading Time:
  • 51 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 24%
  • Publisher: 97%

Sarepta Therapeutics Inc. shares rallied in the extended session Tuesday after the biotech drug maker topped Wall Street expectations, and said U.S....

Sarepta Therapeutics Inc.

shares rallied in the extended session Tuesday after the biotech drug maker topped Wall Street expectations, and said U.S. regulators granted a priority review status for its muscular dystrophy drug candidate SRP-9001. Sarepta shares rallied as much as 14% after hours, following a 3.3% rise in the regular session to close at $122.13. The company reported a fourth-quarter loss of $109.2 million, or $1.24 a share, compared with a loss of $122 million, or $1.42 a share, in the year-ago period.

shares rallied in the extended session Tuesday after the biotech drug maker topped Wall Street expectations, and said U.S. regulators granted a priority review status for its muscular dystrophy drug candidate SRP-9001. Sarepta shares rallied as much as 14% after hours, following a 3.3% rise in the regular session to close at $122.13. The company reported a fourth-quarter loss of $109.2 million, or $1.24 a share, compared with a loss of $122 million, or $1.42 a share, in the year-ago period.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

MarketWatch /  🏆 3. in US

Australia Latest News, Australia Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

The 10 best, and the 10 worst, movie threequels ever madeThe 10 best, and the 10 worst, movie threequels ever madeSometimes you get The Lord Of The Rings: The Return Of The King and Toy Story 3—and sometimes you get Batman Forever and Jaws 3-D.
Read more »

Disinformation Inc: Government-backed group tried to punish sites boosting COVID lab leak theoryDisinformation Inc: Government-backed group tried to punish sites boosting COVID lab leak theoryThis is part of a Washington Examiner series on self-styled 'disinformation' tracking groups that are blacklisting and trying to defund conservative media. Here is where you can read other stories in the series.
Read more »

Kawasho Foods USA Inc. recalls canned shrimp product for leakingKawasho Foods USA Inc. recalls canned shrimp product for leakingThe canned product was sold by major retailers including Walmart, Albertsons in California, Colorado and Utah and Safeway.
Read more »

10 Best Whiskies to Start Your Collection10 Best Whiskies to Start Your CollectionGo forth and start collecting. Here are ten bottles — mostly affordable, as single malts go, but with a couple of splurges — to get you started.
Read more »

Auburn’s top 10 NFL receivers: A new name hits the listAuburn’s top 10 NFL receivers: A new name hits the listThese are the top 10 NFL receivers who played at Auburn (as ranked by career receiving yards):
Read more »

Study ranks San Antonio among top 10 best cities in which to retireStudy ranks San Antonio among top 10 best cities in which to retireSan Antonio received high marks for its world-class healthcare options and warm weather. SanAntonio SATX SanAntonioTX Texas Retirement
Read more »



Render Time: 2025-02-27 08:39:25